SCS
Human challenge studies SCS11
Auditorium 2 - Breakout
Chair
Ended
Now live
Upcoming
-
Disease characteristics and immunological profiles obtained from a newly developed hMPV human challenge modelBrandon LONDThVIVO, UK
-
Evolution of Human Metapneumovirus (HMPV) over the last 20 years and superior isolation of HMPV from clinical samples in organoid-derived bronchial cell cultures to isolation in monolayer cell line culturesBernadette VAN DEN HOOGENErasmusMC, Netherlands
-
A Study of the Efficacy, Safety and Immunogenicity of mRNA vaccines in an Influenza B Challenge Model in Healthy AdultsAnita GEEVARUGHESEPfizer, United States
-
Development of a Severe Acute Respiratory Syndrome – Coronavirus 2 (SARS-CoV-2) Omicron BA5 human challenge model (HCM) for the assessment of new vaccine and anti-viral therapies in seropositive subjectsAndrew CATCHPOLEhVIVO, UK
-
Establishing a Controlled Human Infection Model with a contemporary Respiratory Syncytial Virus B challenge agent in healthy volunteersTo be confirmed